Chinese medicine composition for treating myelodysplastic syndrome
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A bone marrow dysplasia and composition technology, which is applied in the direction of drug combination, active ingredients of hydroxyl compounds, and pharmaceutical formulations, can solve the problems of inconvenient preparation and use, long time of taking, and more medicinal taste, so as to increase the concentration of hemoglobin and be suitable for long-term use , the effect of improving the quality of life
Active Publication Date: 2015-06-17
YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
View PDF7 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
These medicines have a certain curative effect, but there are also some problems, such as slow onset of medicine, more medicinal smell, inconvenient preparation and use, not very obvious effect, long taking time, unstable curative effect, etc.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0019] 1500 parts of gardenia, 3300 parts of tangerine peel, 900 parts of fried cortex, 2800 parts of heterophylla, 900 parts of roasted licorice with honey, 1500 parts of coptis, 3300 parts of waist yellow, 300 parts of borneol, 900 parts of bran fried Atractylodes macrocephala, 1500 parts of artificial bezoar, musk 0.7 parts, 3300 parts of Scutellaria baicalensis.
Embodiment 2
[0021] 1520 parts of gardenia, 3280 parts of tangerine peel, 920 parts of fried cortex, 2780 parts of heterophylla, 880 parts of honey-roasted licorice, 1520 parts of coptis, 3280 parts of waist yellow, 320 parts of borneol, 880 parts of bran fried Atractylodes macrocephala, 1520 parts of artificial bezoar, musk 0.72 parts, 3280 parts of Scutellaria baicalensis.
Embodiment 3
[0023] 1540 parts of gardenia, 3260 parts of tangerine peel, 940 parts of fried cortex, 2760 parts of heterophylla, 860 parts of honey-roasted licorice, 1540 parts of coptis, 3260 parts of waist yellow, 340 parts of borneol, 60 parts of bran fried Atractylodes macrocephala, 1540 parts of artificial bezoar, musk 0.75 parts, 3260 parts of Scutellaria baicalensis.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a Chinese medicine composition for treating myelodysplastic syndrome. The Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 1,500-1,700 parts of jasmine, 3,100-3,300 parts of dried orange peel, 900-1,100 parts of fried golden cypress, 2,600-2,800 parts of radix pseudostellariae, 700-900 parts of honey-fried licorice root, 1,500-1,700 parts of coptis chinensis, 3,100-3,300 parts of yellow-rumped, 300-500 parts of borneol, 700-900 parts of atractylodes stir-baked with bran, 1,500-1,700 parts of calculus bovis factitius, 0.7-0.9 part of musk and 3,100-3,300 parts of scutellaria baicalensis. The Chinese medicine composition has the advantages that the matching meets the assistant and guide principle of Chinese medicines, the Chinese medicine syndrome curative effects of the Chinese medicine composition in treating myelodysplastic syndrome are remarkably superior to that of the ordinary western treatment, the hemoglobin concentration in peripheral blood is improved, the patient life quality is improved, less untoward effects are caused, the security is superior to that of ordinary western treatment, and the Chinese medicine composition is suitable for long-term use.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating myelodysplastic syndrome. Background technique [0002] Myelodysplastic syndromes (myelodysplastic syndromes, MDS) are a group of heterogeneous myeloid clonal diseases originating from hematopoietic stem cells, characterized by abnormal differentiation and development of myeloid cells, manifested as ineffective hematopoiesis, refractory hematopoiesis, hematopoietic Functional failure, high risk of transformation to acute myeloid leukemia (AML). [0003] MDS treatment mainly solves two major problems: bone marrow failure and complications, and AML transformation. As far as the patient population is concerned, the natural course and prognosis of MDS patients are very different, and the treatment should be individualized. According to the prognosis score of MDS patients, combined with the patient's age, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more